Elizabeth Chang

Elizabeth Chang

Elizabeth Chang initially joined XenoTherapeutics in 2019 through Northeastern's Co-Op program. Since then, she has lead the Xeno-Nerve preclinical research program, while simultaneously working towards her bachelors and masters degrees in Bioengineering which she will receive in May of 2022.

She has been published in the journals Xenotransplantation, Journal of Burn Care and Research, and is an inventor on more than 20 United States and international patents.